Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Szabo Insider Profile
4 Followers
John Szabo, Director at Molina Healthcare, holds 1.16M shares in Wag! Group (Ticker: PET), holds 18.60K shares in Molina Healthcare (Ticker: MOH). Most recently, John Szabo Bought ― shares of Wag! Group on Jul 19, 2024 for an estimated value of 1.47M.
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-32.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Szabo holds in companies
Most Profitable Insider Trade
The most profitable trade made by John Szabo
John Szabo's Trading History
Molina Healthcare
Apr 03, 2015
Director
Uninformative Buy
61.60K
$5.34M
Wag! Group
Jul 19, 2024
Ten Percent Owner
Informative Buy
1.47M
$1.52M
List of latest transactions for each holding click on a transaction to see John Szabo's performance on stock
You May Also Like
John Szabo insider profile FAQ
What is the percentage of profitable transactions made by John Szabo?
The percentage of profitable transactions made by John Szabo is 0%.
What is the average return per transaction made by John Szabo?
The average return per transaction made by John Szabo is -32.70%.
What stocks does John Szabo hold?
John Szabo holds: MOH, PET stocks.
What was John Szabo’s latest transaction?
John Szabo latest transaction was an Informative Buy of $1.47M.
What was John Szabo's most profitable transaction?
John Szabo’s most profitable transaction was an Informative Buy of PET stock on July 19, 2024. The return on the trade was 0.00%.
What is John Szabo's role in Molina Healthcare?
John Szabo's role in Molina Healthcare is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.